Why the study?
Do new serotype 1 and 2 vaccines improve protection against Marek's disease in chickens compared to commercial vaccines?
Population
Chickens challenged with virulent and very virulent Marek's disease viral strains
Comparison
New monovalent and polyvalent vaccines based on… vs Commercially available vaccines, including…
Design
Preclinical
Authors
Loading...
Supports advancement of these candidates to field trials; leaves open commercial translation in poultry.
Do new serotype 1 and 2 vaccines improve protection against Marek's disease in chickens compared to commercial vaccines?
New monovalent and polyvalent vaccines based on 301B/1 and Md11/75C/R2 isolates provide superior protection against Marek's disease in chickens compared to standard commercial vaccines.
R. L. Witter (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: